IL2 and myeloid sarcoma: Several studies suggest that excess levels of circulating Th1 cytokines (IL-2, IL-12, and IFNγ) and Th17 cytokines (IL-17, IL-21, and IL-23) correlate with the pathogenesis of MS, indicating the overactivation of these cell types in MS patients [58].